title: "Real-Life" comparison of pegylated-interferon 2a versus 2b combination therapy of chronic hepatitis C virus.
authors.forename: Julian
authors.initials: J
authors.lastname: Schulze Zur Wiesch
authors.forename: Neele
authors.initials: N
authors.lastname: Pudelski
authors.forename: Lena
authors.initials: L
authors.lastname: Hoepner
authors.forename: Michael
authors.initials: M
authors.lastname: Supplieth
authors.forename: Peter
authors.initials: P
authors.lastname: Buggisch
authors.forename: Ansgar W
authors.initials: AW
authors.lastname: Lohse
authors.forename: Stefan
authors.initials: S
authors.lastname: Lüth
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic / Q000379:methods; D011994:Recombinant Proteins; D012254:Ribavirin / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C417083:peginterferon alfa-2b; C100416:peginterferon alfa-2a